From January 1, 2024 to March 31, 2024, the company has repurchased 9,701,000 shares, representing 0.51% for CNY 37.39 million. With this, the company has completed the repurchase of 37,232,540 shares, representing 1.93% for CNY 164.86 million under the buyback announced on July 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.88 CNY | -0.26% | -2.76% | -12.61% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.61% | 1.03B | |
+41.06% | 6.26B | |
-15.95% | 4.49B | |
+6.36% | 3.29B | |
-11.34% | 3.12B | |
-3.12% | 2.5B | |
+45.41% | 1.94B | |
-7.74% | 1.68B | |
-0.67% | 1.63B | |
-11.32% | 1.56B |
- Stock Market
- Equities
- 002390 Stock
- News Guizhou Xinbang Pharmaceutical Co., Ltd.
- Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.